Speaking of NGIO shares, I know someone brought th
Post# of 36537
"NuGenerex Immuno-Oncology, Inc. (“NGIO”), a Delaware corporation and subsidiary of Generex, has 750,000,000 authorized shares of common stock, 400,300,000 of which are outstanding, and prior to two stock dividends completed by Generex, were all held by Generex."